76731-210 CELGEN Pearl Moisture Solution Mask

CELGEN Pearl Moisture Solution Mask by

Drug Labeling and Warnings

CELGEN Pearl Moisture Solution Mask by is a Otc medication manufactured, distributed, or labeled by BBHC CO., LTD, STC Nara Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

CELGEN PEARL MOISTURE SOLUTION MASK- adenosine, niacinamide lotion 
BBHC CO., LTD

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

76731-210 CELGEN Pearl Moisture Solution Mask

Active ingredient

Niacinamide (2.00%)

Adenosine (0.04%)

Purpose

Skin Brightening

Anti wrinkle

Uses

  • Helps improve skin brightness and wrinkle care.
  • Helps moisturize dehydrated skin.

Warnings

For external use only

Do not use

on damaged or broken skin.

When using this product

keep out of eyes.

Rinse with water to remove.

Stop use and ask a doctor if

rash occurs.

Keep out of reach of children.

If porducts is swallowed, get medical help
or contact a Poison Control Center right away.

Directions

1) After washing the face, even out the skin texture with toner.
2) Open the pouch and apply the sheet on the face.
3) Remove the sheet after about 15 to 30 minutes.
4) Lightly tap the remaining essence to absorb it into your skin.

Inactive ingredients

Water, Butylene Glycol, Glycerin, Panthenol, Betaine, Arginine, Carbomer, Allantoin, Xanthan Gum, Sodium Hyaluronate, Pearl Extract, DNA, Hydrolyzed collagen, Algae Extract, Plankton Extract, Glyceryl Acrylate/Acrylic Acid Copolymer, Caprylhydroxamic Acid, Propanediol, Polysorbate 80, Propylene Glycol, PVM/MA Copolymer, Citric Acid, Fragrance, Silver, Silica, Lecithin, Zinc Oxide, Disodium EDTA, Sodium Chloride, Glucose, Ethylhexylglycerin

Package Label

76731-211

CELGEN PEARL MOISTURE SOLUTION MASK 
adenosine, niacinamide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 76731-210
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE2 g  in 100 g
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.04 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
PHYMATOLITHON CALCAREUM (UNII: 6J1M3WA0ZK)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ZINC OXIDE (UNII: SOI2LOH54Z)  
ANHYDROUS DEXTROSE (UNII: 5SL0G7R0OK)  
ARGININE (UNII: 94ZLA3W45F)  
XANTHAN GUM (UNII: TTV12P4NEE)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
WATER (UNII: 059QF0KO0R)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
GLYCERIN (UNII: PDC6A3C0OX)  
PANTHENOL (UNII: WV9CM0O67Z)  
BETAINE (UNII: 3SCV180C9W)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
CAPRYLHYDROXAMIC ACID (UNII: UPY805K99W)  
SILVER (UNII: 3M4G523W1G)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
ALLANTOIN (UNII: 344S277G0Z)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
PROPANEDIOL (UNII: 5965N8W85T)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 76731-210-01125 g in 1 BOX; Type 0: Not a Combination Product07/20/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/20/202105/01/2023
Labeler - BBHC CO., LTD (689522401)
Registrant - STC Nara Co., Ltd (689135085)
Establishment
NameAddressID/FEIBusiness Operations
STC Nara Co., Ltd689135085manufacture(76731-210)

Revised: 5/2023
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.